116 related articles for article (PubMed ID: 6104382)
21. [Therapy of coronary heart disease].
Niederberger M
Wien Med Wochenschr; 1976 Aug; 126(32-35):469-73. PubMed ID: 11611
[No Abstract] [Full Text] [Related]
22. [Conservative treatment of coronary heart disease].
Bachmann K
Fortschr Med; 1976 Nov; 94(32):1821-5. PubMed ID: 11160
[No Abstract] [Full Text] [Related]
23. [Experience in treatment of patients with ischemic heart disease by means of beta adrenergic blocking agents].
Lebedev SV
Klin Med (Mosk); 1977 May; 55(5):54-7. PubMed ID: 17769
[No Abstract] [Full Text] [Related]
24. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
25. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
26. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1996; 59(2):24-6. PubMed ID: 8974558
[TBL] [Abstract][Full Text] [Related]
27. [Use of beta-adrenergic blocking agents and anabolic steroids in ischemic heart disease].
Girina NI
Vrach Delo; 1979 Dec; (12):48-50. PubMed ID: 43030
[No Abstract] [Full Text] [Related]
28. [The value of drug therapy in coronary disease].
Stauch M
ZFA (Stuttgart); 1979 Oct; 55(28):1577. PubMed ID: 44408
[No Abstract] [Full Text] [Related]
29. [Importance of obsidan for increasing exercise tolerance in elderly patients with ischemic heart disease].
Kotko DN; Fed'ko GP; Iaroshenko IuT
Ter Arkh; 1980; 52(8):22-5. PubMed ID: 6114575
[No Abstract] [Full Text] [Related]
30. [Results of the use of various psychotropic drugs in the treatment of chronic forms of ischemic heart disease under polyclinical conditions].
Efimov VV; Zaĭtsev VP
Ter Arkh; 1978; 50(8):29-30. PubMed ID: 694758
[No Abstract] [Full Text] [Related]
31. [Prevention of sudden death in ischemic heart disease].
Tsolov Ts
Vutr Boles; 1980; 19(6):14-21. PubMed ID: 6111160
[No Abstract] [Full Text] [Related]
32. [Immediate effect of beta-blockaders on coronary patients during exertion].
Vastesaeger MM; Rasson G
Brux Med; 1971 Jun; 51(6):429-36. PubMed ID: 4397872
[No Abstract] [Full Text] [Related]
33. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
Reiterer W
Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
[TBL] [Abstract][Full Text] [Related]
34. [Coronary reserve and differentiated therapy of its disorder].
Kukes VG; Kniazev MD; Vorobkov AI; Semenov VN; Abugov AM
Kardiologiia; 1975 Jun; 15(6):52-7. PubMed ID: 241874
[TBL] [Abstract][Full Text] [Related]
35. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy.
Brawner CA; Ehrman JK; Schairer JR; Cao JJ; Keteyian SJ
Am Heart J; 2004 Nov; 148(5):910-4. PubMed ID: 15523326
[TBL] [Abstract][Full Text] [Related]
36. [Health care quality: medication and prevention in patients with and without coronary heart disease].
Baberg HT; Yazar A; Brechmann T; Grewe P; Kugler J; De Zeeuw J; Bojara W; Lawo T; Mügge A
Med Klin (Munich); 2004 Jan; 99(1):1-6. PubMed ID: 14716479
[TBL] [Abstract][Full Text] [Related]
37. [Changes in indicators of the antioxidant defense system in patients with ischemic heart disease treated conventionally].
Syrkin AL; Barsel' VA; Alliluev IG; Kogan IG; Aksiutina MS; Eliubaeva ID; Nesmeianova MA; Drozdov DV
Klin Med (Mosk); 1996; 74(3):24-7. PubMed ID: 8926695
[TBL] [Abstract][Full Text] [Related]
38. [Features of the course of silent myocardial ischemia and choice of therapeutic policy].
Syrkin AL; Smulevich AB; Drozdov DV; Drobizhev MIu; Pecherskaia MB
Klin Med (Mosk); 1996; 74(3):42-4. PubMed ID: 8926701
[No Abstract] [Full Text] [Related]
39. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
Kolenda KD
Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
[No Abstract] [Full Text] [Related]
40. [Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?].
Böger GI; Hoopmann M; Busse R; Budinger M; Welte T; Böger RH
Z Kardiol; 2003 Jun; 92(6):466-75. PubMed ID: 12819995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
